Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Mark Libardoni
Funded by
Connecting through Research Partnerships (Connect) program
Collaborating Institutions
The University of Texas at San Antonio
Researchers from Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) are developing techniques to detect traumatic brain injury (TBI) by analyzing breath for specific biomarkers. The project, led by SwRI’s Dr. Mark Libardoni and UTSA’s Dr. Marzieh Memar and Dr. Morteza Seidi, is supported by a $125,000 grant from the Connecting through Research Partnerships (Connect) program.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Koen Flores
Funded by
SwRI
Diagnostic errors committed by radiologists can have serious consequences on patient outcomes. These diagnostic errors have considerable impact in the field of oncology as most errors occur during radiological diagnosis. Radiologist fatigue is widely accepted as a significant contributor to diagnostic errors and is expected to increase as physician workloads have climbed in recent years. Both eye gaze and speech patterns have been studied to identify possible indicators of fatigue outside the field of radiology.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Liu, Aimin
Funded by
Purdue Univ
The tryptophan degradation pathway is used to prevent unrestrained immune activation in healthy cells. However. tumors hijack this mechanism to escape immune surveillance. The key enzyme of this pathway. tryptophan 2.3-dioxygenase (TDO) and indoleamine 2.3-dioxygenase (IDO). are established immune checkpoint proteins. Tumors enhance their expression to block T cell proliferation and induce T cell death. thereby avoiding immune system surveillance and increasing tumor cell migration capacity. Thus.
